Biotech

All Articles

Takeda takes $140M loss on stopped working epilepsy drug, promotes FDA run

.We currently recognize that Takeda is expecting to locate a road to the FDA for epilepsy medicine s...

VBI Injections files for bankruptcy, finds possession sale

.Immunology biotech VBI Vaccines is veering dangerously close to the defining moment, along with str...

Celldex anti-cKIT antibody lower hives in another period 2 research study

.It is actually not easy to muscle in on an area as affordable as immunology, however Celldex Therap...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics and also a preclinical imm...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's disease medication performed not assist people obtain remission in a st...

Cognition's period 2 beam data stain Alzheimer's prospect

.Knowledge Therapeutics' period 2 SHINE trial has actually taken some of the radiance off the Alzhei...

BMS centers bispecific months after filing to work period 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that looked after Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squ...

Asarina to shut after attempts to partner Tourette's drug neglect

.After communicating to greater than 200 providers to companion a Tourette syndrome treatment that r...

Novartis markers $150M in advance bispecifics handle Dren Biography

.Novartis has actually had some bad luck along with bispecific antitoxins before, but evaluating due...